PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23710442-0	2013	Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K/Akt signal pathway.	Dexamethasone	0-13	AKT serine/threonine kinase 1	Homo sapiens	66-69	
23710442-3	2013	In contrast, DEX restores CD2AP-PI3K-Akt-GSK3 beta signaling, which promotes the activity of antiapoptotic proteins and inhibits the activity of proapoptotic proteins.	Dexamethasone	13-16	AKT serine/threonine kinase 1	Homo sapiens	37-40	
23710442-7	2013	DEX treatment induced a concentration-dependent reversal of PAN-induced p-Akt and p-GSK3 beta downregulation.	Dexamethasone	0-3	AKT serine/threonine kinase 1	Homo sapiens	74-77	
23710442-12	2013	These results strongly suggest that DEX protects podocytes by stabilizing the expression and subcellular distribution of CD2AP and by maintaining the expression of phosphor-activated Akt and GSK3beta .	Dexamethasone	36-39	AKT serine/threonine kinase 1	Homo sapiens	183-186